PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Diabetic Macular Edema
Related studies linked through entity extraction aliases.
Dextromethorphan for Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Efficacy and Safety of Betamethasone Microsphere in Patients With Diabetic Macular Edema (TSUBASA)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Patients With Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE3
Glycemic Control and Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- N/A
Evaluation of the Effects of Selective Photocoagulation for the Treatment of Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Intravitreal Bevacizumab and Triamcinolone in Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- NA
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy by Multiple Injection of KH902 in Patients With Diabetic Macular Edema (DME)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Efficacy Study of Topical Administration of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic Retinopathy
- Status
- COMPLETED
- Phase
- PHASE2
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
- Status
- COMPLETED
- Phase
- N/A
Ozurdex as Adjunct to Avastin Compared to Avastin Alone in Treatment of Patients With Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE4
Fluocinolone Acetonide in Diabetic Macular Edema (FAME) Extension Study
- Status
- COMPLETED
- Phase
- PHASE3
Ranibizumab "Treat and Extend" in Diabetic Macular Edma
- Status
- COMPLETED
- Phase
- PHASE4
Ranibizumab 0.5mg and 2.0mg to Treat Diabetic Macular Edema in Patients With Poor Response to Bevacizumab
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ozurdex for Combined Pseudophakic Cystoid Macular Edema and Diabetic Macular Edema After Cataract Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Changes in Ciliary Body Thickness in Patients With Diabetic Macular Edema After Vitrectomy
- Status
- COMPLETED
- Phase
- NA
Ranibizumab as a Rescue Therapy for Diabetic Macular Edema
- Status
- WITHDRAWN
- Phase
- PHASE2
Anterior and Posterior Segment Vascular Changes Following Laser and Anti-Vascular Endothelial Growth Factor (VEGF) Treatment of Diabetic Retinopathy
- Status
- UNKNOWN
- Phase
- N/A
Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE3